Search News Archives
Follow us on
Conferences | Events

Media Partners

 

New Economic Models Post Brexit

publication date: Oct 29, 2018
 | 
author/source: Kolabtree

Imperial College LondonImperial College London has signed a partnership with the Technical University of Munich, to jointly recruit and deliver academic dual nationality for research staff.

Through the partnership, UK academics, in areas such as bioengineering, computer science and aerospace, will have access to EU funding even after Brexit.

The priority for any research project is to achieve its scientific objectives. To remain competitive, it is vital that the UK develops new funding and employment models, so we do not limit scientific progress.

Imperial College London’s project demonstrates a creative way to access ongoing EU funding. However, we shouldn’t treat EU funding as the pot of gold at the end of the Brexit rainbow. We should develop new economic models, such as commercial or UK funding or hiring freelance scientists to be more competitive. Hiring freelance PhD level scientists also removes international barriers and provides low-cost access to specialist skills.

Ongoing research is critical in solving the environmental, medical and engineering challenges of the future. Imperial College has taken a leading stance by thinking creatively and I urge the rest of the scientific community to do the same.




 

Popular this Month

 

Chromatography in Cannabis Testing

 

New Catalogue of Infectious Disease Antibodies and Antigens

 

Acquisition of B&W Tek takes Metrohm’s Spectroscopy Portfolio to the Next Level

 

Gilson announce the release of the extended mass range VERITY® 1910 MS Detector

 

NanoFCM Opens European Office and Centre of Excellence for Scientific Application Support

 

Hitachi High-Technologies Launches Two New Scanning Electron Microscopes

 

Discovery Park & MedCity to Partner on Prestigious Angels In MedCity Programme

 

Merck Lectureship 2019 Awarded to Susumu Kitagawa

 

BioCity Invests in Carbon Recycling Start-Up, Deep Branch Biotechnology

 

Agilent Announces Unique Portfolio to Advance Immunotherapy

 

 


 

 


 

Can't find what you are looking for?

Search by company or by product


Company Name:

Product:


 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd